Risk Assessment of Accidental Nortriptyline Poisoning: The Importance of Cytochrome P450 for Nortriptyline Elimination Investigated Using a Population-based Pharmacokinetic Simulator Publication Risk Assessment of Accidental Nortriptyline Poisoning: The Importance of Cytochrome P450 for Nortriptyline Elimination Investigated Using a Population-based Pharmacokinetic Simulator It is not possible to make a prospective clinical study that reveals the importance of…CertaraOctober 9, 2011
Evaluation of Combined Bevacizumab and Intraperitoneal Carboplatin or Paclitaxel Therapy in a Mouse Model of Ovarian Cancer Publication Evaluation of Combined Bevacizumab and Intraperitoneal Carboplatin or Paclitaxel Therapy in a Mouse Model of Ovarian Cancer The purpose of this was to evaluate the pharmacokinetics of bevacizumab following IP and IV…CertaraOctober 1, 2011
Pharmacokinetics of SN2310, an Injectable Emulsion that Incorporates a New Derivative of SN-38 in Patients with Advanced Solid Tumors Publication Pharmacokinetics of SN2310, an Injectable Emulsion that Incorporates a New Derivative of SN-38 in Patients with Advanced Solid Tumors SN2310 is an injectable emulsion composed of vitamin E, a succinate derivative, as well as…CertaraOctober 1, 2011
Are There Differences in the Catalytic Activity per Unit Enzyme of Recombinantly Expressed and Human Liver Microsomal Cytochrome P4502C9? A Systematic Investigation into Inter-system Extrapolation Factors Publication Are There Differences in the Catalytic Activity per Unit Enzyme of Recombinantly Expressed and Human Liver Microsomal Cytochrome P4502C9? A Systematic Investigation into Inter-system Extrapolation Factors The 'relative activity factor' (RAF) compares the activity per unit of microsomal protein in recombinantly…CertaraSeptember 1, 2011
Effects of the Moderate CYP3A4 Inhibitor, Fluconazole, on the Pharmacokinetics of Fesoterodine in Healthy Subjects Publication Effects of the Moderate CYP3A4 Inhibitor, Fluconazole, on the Pharmacokinetics of Fesoterodine in Healthy Subjects Available data suggest that fesoterodine dosage should not exceed 4 mg once daily when taken…CertaraAugust 1, 2011
In Vitro-In Vivo Extrapolation of CYP2C8-catalyzed Paclitaxel 6a-hydroxylation: Effects of Albumin on In Vitro Kinetic Parameters and Assessment of Interindividual Variability in Predicted Clearance Publication In Vitro-In Vivo Extrapolation of CYP2C8-catalyzed Paclitaxel 6a-hydroxylation: Effects of Albumin on In Vitro Kinetic Parameters and Assessment of Interindividual Variability in Predicted Clearance This study aimed to characterize the effects of bovine serum albumin (BSA) on the kinetics…CertaraAugust 1, 2011
Ammonia Control in Children with Urea Cycle Disorders (UCDs); Phase 2 Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate Publication Ammonia Control in Children with Urea Cycle Disorders (UCDs); Phase 2 Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate Twenty four hour ammonia profiles and correlates of drug effect were examined in a phase…CertaraAugust 1, 2011
How Can PK/PD Analysis Add Value to Patient Care? Knowledge Base How Can PK/PD Analysis Add Value to Patient Care? In May 2011, T.J. Smith and B.E. Hillner published an opinion piece in the New…CertaraJuly 11, 2011
What is Curve Stripping? Knowledge Base What is Curve Stripping? The process of curve stripping is used in both compartmental and non-compartmental analysis. Each pharmacokinetic…CertaraJuly 6, 2011
Pharmacokinetic-pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-induced Arthritis Publication Pharmacokinetic-pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-induced Arthritis The purpose of this study was to develop a pharmacokinetic-pharmacodynamic disease progression (PK/PD/DIS) model to…CertaraJuly 1, 2011